Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10594199 | Bioorganic & Medicinal Chemistry Letters | 2012 | 4 Pages |
Abstract
We conducted a high throughput screening for glyoxalase I (GLO1) inhibitors and identified 4,6-diphenyl-N-hydroxypyridone as a lead compound. Using a binding model of the lead and public X-ray coordinates of GLO1 enzymes complexed with glutathione analogues, we designed 4-(7-azaindole)-substituted 6-phenyl-N-hydroxypyridones. 7-Azaindole's 7-nitrogen was expected to interact with a water network, resulting in an interaction with the protein. We validated this inhibitor design by comparing its structure-activity relationship (SAR) with that of corresponding indole derivatives, by analyzing the binding mode with X-ray crystallography and by evaluating its thermodynamic binding parameters.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Takashi Chiba, Jun Ohwada, Hiroshi Sakamoto, Takamitsu Kobayashi, Takaaki A. Fukami, Machiko Irie, Takaaki Miura, Kazuhiro Ohara, Hiroshi Koyano,